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a b s t r a c t
etv2 is an endothelial-speciﬁc ETS transcription factor that is essential for vascular differentiation and
morphogenesis in vertebrates. While recent data suggest that Etv2 is dynamically regulated during vascular
development, little is known about the mechanisms involved in this process. Here, we ﬁnd that etv2
transcript and protein expression are highly dynamic during zebraﬁsh vascular development, with both
apparent during early somitogenesis and subsequently down-regulated as development proceeds. Inducible
knockdown of Etv2 in zebraﬁsh embryos prior to mid-somitogenesis stages, but not later, caused severe
vascular defects, suggesting a speciﬁc role in early commitment of lateral mesoderm to the endothelial linage.
Accordingly, Etv2-overexpressing cells showed an enhanced ability to commit to endothelial lineages in
mosaic embryos. We further ﬁnd that the etv2 3' untranslated region (UTR) is capable of repressing an
endothelial autonomous transgene and contains binding sites for members of the let-7 family of microRNAs.
Ectopic expression of let-7a could repress the etv2 3'UTR in sensor assays and was also able to block
endogenous Etv2 protein expression, leading to concomitant reduction of endothelial genes. Finally, we
observed that Etv2 protein levels persisted in maternal-zygotic dicer1 mutant embryos, suggesting that
microRNAs contribute to its repression during vascular development. Taken together, our results suggest that
etv2 acts during early development to specify endothelial lineages and is then down-regulated, in part
through post-transcriptional repression by microRNAs, to allow normal vascular development.
& 2013 Elsevier Inc. All rights reserved.
Introduction
The vertebrate circulatory system serves as an essential conduit for
the systemic distribution of oxygenated blood, nutrients, hormones,
immunological factors and the removal of metabolic waste. The
formation of a patent and functional circulatory system begins before
the onset of blood circulation with the speciﬁcation of endothelial
progenitors, or angioblasts, from the lateral mesoderm. As angioblasts
differentiate and express an endothelial gene program, they migrate
and coalesce to form vascular cords through a process called vascu-
logenesis (Cleaver and Krieg, 1999; Risau and Flamme, 1995). This
initial vascular plexus is subsequently remodeled and extended into a
system of patent blood vessels through a process referred to as
angiogenesis (Cleaver and Krieg, 1999). While the morphological
events that deﬁne vasculogenesis and angiogenesis are relatively
well-deﬁned, the transcriptional regulatory networks that control
angioblast speciﬁcation and subsequent endothelial differentiation
are poorly understood.
Multiple transcription factor families have been implicated in
the activation and maintenance of endothelial gene expression,
including members of the Sox, Forkhead, GATA, and Krüppel-like
families (De Val and Black, 2009). Among the most prevalent
transcription factors involved in endothelial biology are members
of the ETS family. ETS transcription factors are deﬁned by the
presence of a conserved, approximately 85-amino acid DNA-
binding domain, referred to as the ETS domain, which consists of
a winged helix-turn-helix motif that binds a core DNA sequence of
5'-GGA(A/T)-3' (Sharrocks, 2001). There are numerous ETS factors
expressed in vertebrate endothelial cells including ETS1, ETS2,
ETV2 (etsrp/ER71), ETV6 (TEL), FLI1, ERG and ELK3 (NET/SAP2; De
Val and Black, 2009; Dejana et al., 2007; Lelievre et al., 2001). Most
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characterized endothelial gene promoters or enhancers contain
essential ETS-binding sites (De Val et al., 2008; Dejana et al., 2007;
Hollenhorst et al., 2004; Liu and Patient, 2008) and it has been
proposed that nearly every endothelial gene may be regulated by
ETS factors in some manner (Dejana et al., 2007). Indeed, the
founding member of the ETS family, Ets1, which is highly
expressed in endothelial cells in multiple species (Maroulakou
et al., 1994; Pham et al., 2007; Stiegler et al., 1993), is capable of
directly binding to elements ﬂanking genes encoding receptors
important for vascular morphogenesis, including Vegf receptors-1
and -2 (Flt1 and Kdr, respectively; Kappel et al., 2000; Wakiya
et al., 1996), Tie-2 (Iljin et al., 1999), and neuropilin-1 (Teruyama
et al., 2001). Targeted deletion or knockdown of individual ETS
factors can cause speciﬁc developmental defects in embryonic
vascular morphogenesis or function, although in many cases mice
bearing single gene deletions are viable. For example, mouse
embryos lacking ﬂi1 alone die at E12.5 due to poor blood vessel
integrity and cranial hemorrhage (Spyropoulos et al., 2000). By
contrast, Ets1-deﬁcient mice are viable with no overt vascular
defects (Barton et al., 1998) and only mild defects have been noted
following knockdown of ets1 in zebraﬁsh (Pham et al., 2007). The
highly conserved DNA binding domain shared between ETS factors
and their overlapping expression in endothelial cells likely con-
tributes to some degree of functional redundancy that reduces the
severity of vascular defects in these cases. Indeed, ETS factors share
signiﬁcant consensus DNA-binding speciﬁcity (Wei et al., 2010) and
can bind to and transactivate the same consensus sequences in some
promoters (Hollenhorst et al., 2004, 2011). Analysis of double knock-
out mice further supports at least partially overlapping functions
among some ETS factors. For example, mouse embryos lacking either
Ets1 or Ets2 alone display relatively normal vascular development.
However, combined loss of both Ets1 and 2 leads to embryonic
lethality between E11.5 and E15.5 due in part to defects in vessel
remodeling and diminished angiogenic branching (Wei et al., 2009).
Similarly, combined reduction of related ETS factors in zebraﬁsh
results in a higher penetrance of defects and a block in angiogenesis
(Pham et al., 2007).
In contrast to the milder vascular phenotypes associated with
loss of some endothelial ETS factors, mouse or zebraﬁsh embryos
lacking Ets-variant protein 2 (Etv2; also known as Ets-related
protein/Etsrp and ER71) show profound defects at the earliest
stages of vascular development. Etv2-deﬁcient mouse embryos fail
to specify hematopoietic and endothelial cell lineages leading to
embryonic lethality at E9.5 due to a failure to develop a functional
circulatory system (Ferdous et al., 2009; Lee et al., 2008). Zebraﬁsh
etv2 mutants and morphants exhibit severe reduction in the
expression of most endothelial genes, including, kdrl, ﬂt4, cdh5,
and plxnd1 and display defects in the morphogenesis of the major
trunk blood vessels (Pham et al., 2007; Sumanas and Lin, 2006).
The severe early vascular defects and global effects on endothelial
gene expression in both mouse and zebraﬁsh embryos suggests
that etv2 plays an early role in specifying endothelial cell lineages.
Consistent with this possibility, overexpression Etv2 in both zebraﬁsh
embryos and mouse embryoid bodies can expand endothelial cell
lineages and induce concomitant expression of hundreds of vascular
genes (Gomez et al., 2012; Koyano-Nakagawa et al., 2012; Sumanas
and Lin, 2006; Wong et al., 2009). Furthermore, recent studies
demonstrate that Etv2 is an essential component, along with Fli1
and Erg, during direct endothelial reprogramming of human amniotic
cells (Ginsberg et al., 2012). Together, these studies suggest a central
role for Etv2 in the early commitment of mesodermal cells to the
endothelial lineage during the initial stages of vascular development.
Despite the importance of Etv2 during early vascular development,
its role during later stages is unclear. Evidence suggests that Etv2 may
only be expressed in endothelial progenitors early during mouse
development (E9.5), while expression in the zebraﬁsh is evident in
angioblasts but appears to be down-regulated by 36 hpf in endothe-
lial cells of the axial vasculature (Ferdous et al., 2009; Lee et al., 2008;
Sumanas and Lin, 2006). Interestingly, mouse embryos are viable
following conditional endothelial ablation of etv2 using a Kdr:Cre
driver (Wareing et al., 2012), suggesting that its function is restricted
to very early stages of vascular development prior to the onset of kdr
expression. Although these studies suggest dynamic control and
function of etv2 expression during embryogenesis, carefully quanti-
ﬁed and staged studies in this regard are still lacking. Furthermore,
the mechanisms that exist to downregulate Etv2 during development
have not been investigated.
In this work, we assessed the expression levels of etv2 transcript
and protein during early zebraﬁsh vascular development. Both
mRNA quantiﬁcation and whole mount immunostaining revealed
that Etv2 is expressed during early and mid-somitogenesis and
subsequently downregulated as endothelial cells differentiate and
form the major trunk blood vessels. Conditional knockdown of Etv2
using a caged morpholino demonstrated that it is required only
during endothelial cell speciﬁcation and appears to be largely
dispensable for subsequent vascular morphogenesis and function.
We further ﬁnd that the etv2 3' UTR is subjected to negative
regulation in endothelial cells and that this effect can be mediated
by members of the let-7 microRNA family. Finally, we observe that
Etv2 protein levels persist in endothelial cells of embryos lacking
maternal and zygotic dicer1, which is required for microRNA
maturation. Together, our results demonstrate that etv2 is required
during a deﬁned developmental window for angioblast speciﬁca-
tion and is actively downregulated, in part, through microRNA-
mediated post-transcriptional regulation.
Results
Based on previous studies that suggested etv2 levels might be
dynamically regulated during embryogenesis, we carefully inves-
tigated its expression during zebraﬁsh vascular development. We
ﬁrst applied the NanoString nCounter gene expression assay to
quantitatively measure etv2 transcript levels at different stages of
development in comparison to other endothelial genes. Using this
approach, we observed that etv2 transcript increases between tail
bud and 10 somite stage (ss) and peaks at 18 ss, at which time it is
expressed nearly 2 fold greater than endothelial transcripts
encoding Fli1a and Fli1b, and the zebraﬁsh Vegf receptor-2
ortholog, Kdrl (Fig. 1A). Subsequently, etv2 transcript decreases
between 18 ss and 48 h post fertilization (hpf), when it is
expressed at levels ﬁve fold below that of kdrl (Fig. 1A). By
contrast, ﬂi1a, ﬂi1b, and kdrl transcripts continued to modestly
increase from 10 ss until 48 hpf (Fig. 1A). Thus, the etv2 transcript
displays an initial burst of expression during the time in which
endothelial commitment and vasculogenesis are taking place and
is subsequently downregulated. We next raised an antibody that
recognized the divergent N-terminal domain of Etv2 and used this
to perform whole mount immunostaining on zebraﬁsh embryos.
The Etv2 antibody did not cross react with other abundant Ets
transcription factors normally found in endothelial cells (e.g. Ets1a,
Fli1a, Fli1b; Supplementary Fig. 1A) and was not detected in
embryos injected with an Etv2 Morpholino (Supplementary
Fig. 1B). Similar to etv2 transcript, we observed Etv2 protein in
the anterior and posterior lateral mesoderm within nuclei of
presumptive endothelial progenitors at 5 ss (Fig. 1B,C) and during
initial formation of the trunk blood vessels at 18 ss (Fig. 1D, E).
However, we did not observe vascular expression of Etv2 protein
at 24 hpf or 48 hpf, while an endothelial-expressed nuclear loca-
lized EGFP (Tg(ﬂi1a:negfp)y7) was easily detectable at both stages in
the same embryos (Fig. 1F, G). By contrast, we observed robust
expression of Fli1b protein in endothelial nuclei of Tg(ﬂi1a:negfp)y7
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Fig. 1. Etv2 is down-regulated during vascular development. (A) Graph of nCounter quantiﬁcation for etv2, ﬂi1a, ﬂi1b, and kdrl at the indicated developmental stages. Values
are normalized to actb2 (beta-actin) and eef1a1l1(ef1alpha). (B, D) Whole mount in situ hybridization using an antisense etv2 riboprobe at 5ss and 18ss. (C, E) Embryos at 5 ss
and 18 ss immunostained with Etv2 antibody and anti-rabbit Alexa-488. (B, C) Dorsal views of ﬂat-mounted embryos, anterior to the left. (D, E) Lateral views, anterior to the
left. (F–I) Two-photon micrographs of trunk vessels in ﬁxed Tg(ﬂi1a:negfp)y7 embryos immunostained with antibodies against (F, G) Etv2 or (H, I) Fli1b. Left panels,
immunostained protein detected with Alexa-568 secondary antibody. Middle panels, transgenic expression of nuclear localized EGFP. Right panels, overlay of Alexa-568 and
EGFP signals. Embryos at (F, H) 25 hpf or (G, I) 48 hpf.
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embryos at the same time points (Fig. 1H, I). Interestingly, etv2 and
ﬂi1b transcript are expressed at similar levels at 24 hpf (Fig. 1A).
Despite its down-regulation in endothelial cells, Etv2 protein was
still detected at 24 hpf in a subset of cells posterior to the caudal
vein plexus, which may comprise hematopoietic precursors
(Bertrand et al., 2007; Supplementary Fig. 1C). We also detected a
small population of weakly stained Etv2-positive cells in circulation
at 48 hpf, while Fli1b was expressed in the majority of blood cells at
this time point (Supplementary Fig. 1D). Taken together, these
observations demonstrate that etv2 transcript and protein are
expressed in angioblasts during vasculogenesis, but are subse-
quently downregulated in endothelial cells as vascular development
proceeds.
The dynamic expression of etv2 suggested that its function
might only be required during early stages of vascular development.
To investigate this possibility, we utilized a caged Morpholino
(cMO) that is activated by exposure to UV light to conditionally
block Etv2 translation at different developmental stages (Ouyang
et al., 2009; Shestopalov et al., 2007). We injected Etv2 cMO into 1-
cell stage Tg(ﬂi1a.ep:DsRedex)um13 zebraﬁsh embryos, exposed them
to UV light at distinct developmental stages, and subsequently
assessed vascular morphology and function. As has been shown
previously (Pham et al., 2007; Sumanas and Lin, 2006), embryos
injected with a standard Morpholino targeting Etv2 exhibited loss
of intersegmental vessels (ISV) and a poorly formed dorsal aorta
(DA) at 30 hpf and did not display circulation at 48 hpf (Fig. 2A, E;
Supplementary Movie 1). By contrast, Tg(ﬂi1a.ep:DsRedex)um13
embryos injected with Etv2 cMO that were not exposed to UV
light, or those that were uninjected and exposed to UV, were
phenotypically normal (Fig. 2B, E; Supplementary Movie 2 and data
not shown). Likewise, Tg(ﬂi1a.ep:DsRedex)um13 embryos injected
with scrambled control morpholino (MO) exhibited normal vascular
morphology at 30 hpf and normal circulation at 48 hpf (Fig. 2E and
data not shown, Supplementary Movie 3). However, most embryos
injected with Etv2 cMO and exposed to UV light at 11 hpf or earlier
exhibited defects in vascular morphology and loss of circulation
(Fig. 2C E, Supplementary Movie 4), similar to embryos injected
with an uncaged Etv2 MO (Fig. 2A, E). In all cases, we did not
observe any overt effects on general morphology (data not shown).
Many fewer Etv2 cMO-injected embryos exposed to UV light at
12 hpf displayed defects in circulation and UV illumination at later
time points did not cause severe defects in trunk blood vessels or
loss of circulation (Fig. 2E, Supplementary Movie 5). Given that Etv2
protein appears to be absent only 1.5 h following activation of the
Etv2 cMO (Supplementary Fig. 1E), these results suggest that Etv2 is
required in a precisely deﬁned early window during vascular
development. Such an early requirement would be consistent with
a role for Etv2 during commitment of lateral mesodermal precur-
sors to an endothelial cell fate. If this were the case we would
expect exogenous Etv2 to increase the potential of cells to con-
tribute to the vascular lineage. Indeed, mosaic analysis revealed that
donor cells derived from Tg(ﬂi1a:egfp)y1 embryos injected with etv2
mRNA were much more likely to contribute to trunk blood vessels
than donor embryos injected with mRNA encoding mCherry
(Fig. 2F, G). Together, these observations demonstrate that Etv2
plays an essential role during endothelial cell speciﬁcation but is
likely dispensable for later aspects of vascular development.
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2013.08.028.
Recent studies in mouse demonstrate that persistent transgenic
expression of Etv2 leads to defects in vascular morphology and
causes a block in endothelial maturation (Hayashi et al., 2012).
Coupled with our observations that Etv2 is robustly downregu-
lated at early stages of vascular development, these results suggest
the existence of mechanisms that actively reduce Etv2 expression.
Furthermore, the discrepancy between Etv2 and Fli1b protein
expression compared to their relative levels of transcript at 24 hpf
(compare Fig. 1A, F, and H) suggested that a post-transcriptional
mechanism might contribute to reduction in Etv2 protein. To
investigate this possibility, we tested the ability of the etv2 3'UTR
to repress reporter gene expression. In the process of cloning the
Fig. 2. Etv2 is required only during early stages of vascular development. (A–D)
Confocal images of trunk blood vessels in Tg(ﬂi1a.ep:DsRedex)um13 embryos at
30 hpf. Lateral views, dorsal is up, anterior to the left. Embryos injected with
(A) 5 ng standard Etv2 Morpholino (MO) or (B) 2 ng Etv2 caged MO (cMO), but not
illuminated with UV light. ISVs (arrows), dorsal aorta (DA; bracket) and posterior
cardinal vein (PCV; bracket) are indicated. (C, D) Embryos injected with Etv2 cMO
exposed to UV light at (C) 3 hpf or (D) 11 hpf. (E) Penetrance of indicated circulatory
defects in embryos at 48 hpf following injection with MO and UV exposure as
indicated. (F) Percentage of mosaic miniRuby-positive host embryos showing
successful transplantation of Tg(ﬂi1:EGFP)y1 donor cells. Donor embryos were
injected with 100 pg of mcherry or etv2 mRNA. *po0.05. (G) Representative
confocal images of wild type hosts with contribution to both vascular (green)
and non-vascular (red) tissue; donor embryos were injected with mRNA encoding
either Etv2 or mCherry.
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appropriate regulatory sequences for this assay, we observed
evidence of alternative 3' UTRs encoded by the etv2 locus. In
ENSEMBL (version 69, Zv9), the annotated etv2 3'UTR spans only
298 nucleotides, while two separate expressed sequence tags (ESTs)
identiﬁed in the NCBI database extend past this sequence by an
additional 315 nucleotides (Supplementary Fig. 2A). To further
characterize expressed etv2 3' UTR sequences, we performed 3'
rapid ampliﬁcation of cDNA ends (RACE) from 24 hpf zebraﬁsh
embryos. Sequence analysis of cloned 3'RACE products and subse-
quent RT-PCR conﬁrmed the expression of both the ENSEMBL- and
EST-annotated 3'UTRs (hereafter referred to as Short and EST 3'
UTR, respectively) as well as a third isoform encoding a 3' UTR of
approximately 1030 nucleotides (Long etv2 3' UTR; Supplementary
Fig. 2A–C). RT-PCR analysis suggests that all three isoforms are
coordinately down-regulated during development (Supplementary
Fig. 2C, D) To determine the regulatory potential of these UTRs, we
employed an endothelial cell autonomous transient transgenic
reporter assay in which a 3' UTR of interest is placed downstream
of a red ﬂuorescent protein (mCherry; Supplementary Fig. 2E;
(Nicoli et al., 2010)). This reporter construct also contains a
separately expressed enhanced green ﬂuorescent protein (EGFP)
reporter fused to a control 3'UTR as an internal reference (Supple-
mentary Fig. 2E). We cloned each etv2 3'UTR downstream of
mCherry and assessed their effect on reporter expression in
endothelial cells in vivo compared to the internal EGFP cassette.
In embryos injected with a transgenic construct encoding mCherry
fused with a control 3'UTR, we observed robust co-expression of
both mCherry and EGFP in endothelial cells within trunk blood
vessels (Fig. 3A). By contrast, both the EST and Long etv2 3'UTRs
caused signiﬁcant reduction of mCherry expression when compared
to the co-expressed EGFP control (Fig. 3B, C), while the Short etv2
3'UTR did not appear to alter expression reporter expression (Fig. 3C
and data not shown). These results suggest that post-transcriptional
control of alternative 3'UTRs may contribute to etv2 regulation
during vascular development.
microRNAs (miRNA) are short non-coding RNAs that can
repress gene expression through interaction with target sequences
usually located in the 3'UTR of transcripts (Du and Zamore, 2005).
Since the EST and Long 3'UTRs repressed reporter gene expression,
we investigated whether this may be due to microRNA regulation.
Analysis of the etv2 3'UTR sequence revealed 5 putative binding
sites for members of the let-7 family of microRNAs in the longest
deﬁned etv2 3'UTR, with the short and EST 3'UTRs having two and
three binding sites, respectively (Supplementary Fig. 2A). Addi-
tionally, let-7 binding sites were also evident in the mouse and
human etv2 transcripts (data not shown), suggesting a conserved
role for let-7 in regulating Etv2 levels. To test the possibility that
Iet-7 regulates the etv2 3'UTR we co-injected zebraﬁsh embryos
with mRNA encoding EGFP fused to the EST or short 3'UTR with
either let-7a or a control duplex RNA, as well as mCherry mRNA
with a control 3'UTR and subsequently compared levels of green
and red ﬂuorescence. Coinjection of the EST 3'UTR sensor with let-
7a duplex decreased EGFP expression compared to control duplex
without an effect on mCherry levels (Fig. 4A, B). Quantiﬁcation of
EGFP and mCherry in the same embryos by Western analysis
demonstrated that let-7a led to signiﬁcant and potent repression
of the EST 3'UTR (Fig. 4E, F). We also observed modest but
signiﬁcant repression of the Short 3' UTR by let-7a (Fig. 4C–F).
Consistent with the highly conserved sequence within let-7
microRNAs, we observed similar repression of the EST 3'UTR by
other let-7 family members (Supplementary Fig. 3), which have
been reported to be expressed in zebraﬁsh endothelial cells at
24 hpf (Nicoli et al., 2012). Furthermore, deletion of the ﬁve
putative let-7 binding sites in the Long 3' UTR resulted in a
signiﬁcant increase in mCherry reporter expression in the
endothelial autonomous sensor assay compared to the wild type
Long 3'UTR (Fig. 3C, data not shown). These observations suggest
that let-7 microRNAs can contribute to the negative regulation of
Etv2 in endothelial cells.
To determine if let-7 could repress endogenous etv2, we
injected let-7a or control duplex into zebraﬁsh embryos and
assessed Etv2 protein and transcript levels. While Etv2 protein
was apparent at low levels in Tg(ﬂi1a:egfp)y1-positive cells lining
the nascent dorsal aorta at 15 ss following injection with control
duplex, we failed to detect it in embryos injected with let-7a
duplex (Fig. 5A). We further noted reduced expression of the ﬂi1a:
egfp transgene in let-7a duplex injected embryos (Fig. 5A), which is
likely due to endothelial differentiation defects as a result of
reduced Etv2 function (Sumanas and Lin, 2006). We also observed
that endogenous etv2 transcript was signiﬁcantly reduced at 15 ss
following injection of the let-7a duplex compared to embryos
injected with control duplex (Fig. 5B). Furthermore, we noted
Fig. 3. The etv2 3'UTR represses a heterologous reporter in endothelial cells. (A, B) Representative confocal micrographs of 48 hpf wild type embryos co-injected with 25 pg
of transposase mRNA and 25 pg of a Tol2 bis-cistronic endothelial cell autonomous sensor construct encoding mCherry fused to a (A) control 3'UTR or the (B) EST etv2 3'UTR
sensor. (Top) Endothelial expression of the control EGFP transgene. (Middle) Endothelial expression of the mCherry sensor transgene. (Bottom) Merge of green and red
channels. Lateral views, dorsal is up, anterior to the left. (C) Quantiﬁcation of relative mCherry ﬂuorescence levels compared to EGFP following 3' UTR sensor injection.
*po0.05, N. S.¼Not signiﬁcant.
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concomitant reduction in ﬂi1a, ﬂi1b, hey2, lmo2, tal1, kdrl, and ﬂt4
in let-7a duplex-injected embryos (Fig. 5B), consistent with the
observation that ectopic Etv2 can induce expression of these
endothelial genes in zebraﬁsh embryos (Gomez et al., 2009,
2012; Wong et al., 2009). Co-injection of etv2 mRNA containing
a heterologous 3'UTR along with let-7a duplex rescued the
expression of these Etv2-responsive genes, suggesting that they
are not directly targeted by let-7a (Fig. 5C). While we observed
repression of several endothelial genes, there was no change in
early hematopoietic markers such as gata1a and gata2a following
injection of let-7a duplex (Fig. 5B). Analysis of etv2 expression by
whole mount in situ hybridization in let-7a injected embryos at 15
ss revealed a slight down-regulation in etv2 expression in the
lateral mesoderm. More strikingly, we observed loss of midline-
positioned etv2-positive cells, which normally comprise the form-
ing aorta (Fig. 5D). This defect is also known to be associated with
Etv2 deﬁciency (Sumanas and Lin, 2006) and is consistent with
reduced Etv2 function as a consequence of ectopic let-7a expres-
sion. We did not note any obvious changes in gata1a (Fig. 5D),
similar to the Nanostring gene expression data (Fig. 5B). Together
Fig. 4. let-7a Negatively regulates the etv2 3'UTR. (A–D) Transmitted light (left column), green ﬂuorescence (middle column) and red ﬂuorescence (right column) images of
embryos injected with sensor mRNAs. (A, B) Embryos co-injected with 25 pg gfp-est-etv2-3' UTR and 25 pg mcherry mRNAs and (A) control or (B) let-7a duplex. (C, D)
Embryos co-injected with 25 pg gfp-short-etv2-3′ UTR and 25 pg mcherry mRNAs and (C) control or (D) let-7a duplex. (E) Western analysis for GFP and mCherry protein on
embryo lysates at 24 hpf following injection with est- or short-etv2 3' UTR sensor mRNA, mcherry mRNA, and indicated duplex. (F) Quantiﬁcation of Western analysis from
three independent experiments. Bars represent the average ratio of GFP band intensities from embryos injected with control duplex compared to let-7a duplex from either
the EST or Short GFP-etv2 3' UTR sensor. Signiﬁcance was calculated using the student t-test. *po0.05.
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these results demonstrate that let-7a can potently repress expres-
sion of the Etv2 protein and lead to reduction in endothelial gene
expression.
To investigate the effect of let-7a over-expression on endothelial
cell commitment, we transplanted cells from Tg(ﬂi1a:egfp)y1
embryos injected with let-7a into wild type embryos and assessed
the frequency of successfully transplanted host embryos with EGFP-
positive donor cells. Consistent with our observation that let-7a can
repress endogenous etv2, signiﬁcantly fewer host embryos trans-
planted with let-7a- overexpressing donor cells displayed contribu-
tion to vascular tissue compared to control duplex-injected
embryos (Fig. 5E). Despite the negative effect of let-7a over-
expression on endothelial cell contribution, let-7a duplex-injected
donor cells were otherwise able to contribute to other cell types
(Fig. 5F). Taken together these data suggest that let-7 family
members can act to limit the ability of Etv2 to induce endothelial
commitment during development.
Determining the effect of let-7 deﬁciency is a challenge due to
the large number of related family members. Indeed, let-7a itself
can be expressed from at least 6 distinct loci in the zebraﬁsh
genome and, including duplication events, there are a total of 18
different let-7 family genes (ENSEMBL, Zv9). As mentioned above,
several of these are expressed in endothelial cells and can repress
the Etv2 3'UTR. Therefore, to reduce let-7 function we over-
expressed lin28a, which uridylates let-7 miRNAs and causes their
rapid degradation (Heo et al., 2008; Nam et al., 2011; Viswanathan
et al., 2008). We ﬁnd that injection of mRNA encoding Lin28a
causes a signiﬁcant decrease in let-7a expression in zebraﬁsh
Fig. 5. Endogenous Etv2 is repressed by let-7a. (A) Two photon images of Tg(ﬂi1a:egfp)y1 embryos injected with control or let-7a duplex and immunostained with Etv2
polyclonal serum and Alexa-568 secondary antibody. Lateral view, dorsal is up, anterior to the left. Arrows denote Etv2/GFP-positive cells (left panels) or Etv2-negative/GFP-
positive cells in the forming dorsal aorta (right panels). (B) Histogram showing fold change in expression of indicated transcripts at 15 ss in embryos injected with let-7a
compared to those injected with control duplex measured by the nCounter system. Genes normalized to actb2 (beta-actin) and eef1a1l1 (ef1alpha). *po0.05. (C) Histogram of
relative nCounter expression counts normalized as in (B) for indicated transcripts following injection with mRNA encoding Etv2 (þEtv2) or Etv2 lacking the DNA binding
domain (no Etv2) and mismatch (no let-7) or let-7a duplex (þ let-7). (D) Whole mount in situ hybridization using riboprobes against etv2 (left) or gata1a (right) at 15 ss in
embryos injected control or let-7a duplex RNA. Angioblasts that have migrated to the midline, or lack thereof, are indicated by arrows. Dorsal view of ﬂat mounted embryo,
anterior is up. (E) Histogram showing percentage of successfully transplanted wild type host embryos (miniRuby-positive) that display contribution to vascular tissue, as
indicated by presence of Tg(ﬂi1a:egfp)y1-positive cells. Donors were injected with control or let-7a duplex as above. Data are from three independent experiments and
signiﬁcance was calculated using the Fisher's exact test; *po0.05. (F) Confocal micrographs showing contribution of Tg(ﬂi1a:egfp)y1 positive cells (green channel) from
donors that were injected with control or let-7 RNA duplex. miniRuby-positive cells (red channel) indicate overall contribution of donor cells in the trunk.
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embryos at 24 hpf (Fig. 6A). This effect was similar for other let-7
family members (Fig. 6B), while mir-126, an unrelated miRNA
expressed speciﬁcally in endothelial cells, was not signiﬁcantly
reduced. Despite reduction in let-7 miRNAs, we did not observe
any signiﬁcant changes in endothelial gene expression at 15 ss or
24 hpf (Fig. 6C). Furthermore, neither etv2 transcript or protein
levels appeared to change signiﬁcantly in Lin28a over-expressing
embryos and vascular development proceeded normally (Fig. 6C,
D). These results raise the possibility that other miRNAs may
contribute to post-transcriptional repression of Etv2 in the
absence of let-7. Alternatively, sufﬁcient levels of let-7 remain to
repress Etv2, even in the presence of increased lin28a. Therefore,
we further investigated whether miRNAs contribute to Etv2 down-
regulation by determining its expression in embryos lacking
maternal and zygotic (MZ) dicer function. dicer1 encodes an
essential nuclease required for miRNA maturation and MZdicer
mutant embryos are devoid of mature miRNAs (Giraldez et al.,
2005). Wild type embryos at 48 hpf did not exhibit Etv2 expression
in endothelial cells (Fig. 6E). By contrast, Etv2 protein expression
was apparent at this stage in embryos lacking both maternal and
zygotic dicer1 (MZdicer1) that had been injected with miR-430 to
rescue early developmental defects associated with a lack of dicer1
(Fig. 6E; (Giraldez et al., 2005)). Despite the persistence of Etv2
protein, down-regulation of etv2 transcript seemed to occur nor-
mally in wild type and MZdicer1 mutant embryos (Supplementary
Fig. 2C). These results suggest that microRNAs may play a role in
post-transcriptionally regulating levels of Etv2 protein during
vascular development.
Discussion
The ETS transcription factor Etv2 is essential for vascular
development, but less is known about its dynamic regulation or
functional requirements during different stages of vascular devel-
opment. Using the zebraﬁsh as a model system, we ﬁnd that both
Fig. 6. Contribution of let-7a and other microRNAs to Etv2 repression. (A) Northern analysis of RNA isolated from 24 hpf embryos left uninjected or injected with 1 ng lin28a
mRNA. Blots were hybridized with DIG labeled probes against let-7a and 5s RNA. (B) Histogram showing log2 fold change comparison of let-7 family members at 15 ss
assessed by miScript qPCR quantiﬁcation between embryos injected with 1 ng lin28a mRNA and those left uninjected, quantiﬁcation from triplicate experiments.
(C) Histogram showing fold change comparison of indicated genes assessed by nCounter quantiﬁcation between embryos injected with 1 ng lin28a and 1 ng βgalactosidase
mRNA. Genes normalized to actb2 (beta-actin) and eef1a1l1(ef1alpha). (D) Two-photon micrographs of trunk blood vessels in Tg(ﬂi1a:egfp)y1 embryos immunostained with
Etv2 polyclonal antiserum and Alexa-568 secondary antibody at 24 hpf following injection with 1 ng of β-galactosidase (left panels) or lin28a mRNA (right panels).
(E) Confocal micrographs of embryos immnuostained with Etv2 polyclonal antiserum and Alexa-568 secondary antibody at 48 hpf. Top, wild type embryo. Bottom,
MZdicer1hu715 mutant embryos injected with mir-430 duplex RNA. Etv2-positive nuclei in the endothelial cells of trunk blood vessels are denoted by arrows (bottom).
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etv2 transcript and protein are expressed during angioblast
speciﬁcation and vasculogenesis, but are subsequently downregu-
lated as development proceeds. This expression pattern is mir-
rored by its functional requirement, which we ﬁnd is restricted to
early stages that correspond to angioblast emergence from the
lateral mesoderm. We further provide evidence that post-
transcriptional control of Etv2 levels likely contributes to its
down-regulation, and this regulation occurs, in part, through let-
7 miRNAs.
The phenotypes of etv2-deﬁcient zebraﬁsh and mouse embryos
suggest that it should be considered as a master regulator of
endothelial cell fates. In both species, loss of etv2 leads to
profound defects in vascular morphogenesis and a global loss of
endothelial gene expression (Lee et al., 2008; Pham et al., 2007;
Sumanas and Lin, 2006). Conversely, exogenous Etv2 expression
can precociously and ectopically induce an endothelial gene
program (Gomez et al., 2009; Wong et al., 2009). Accordingly,
we ﬁnd that Etv2-overexpression can increase the commitment of
cells to the endothelial lineage in mosaic embryos, similar to its
effect in mouse embryoid bodies (Koyano-Nakagawa et al., 2012).
While our results indicate that Etv2 is essential for endothelial cell
commitment, it appears to be dispensable for later steps of
vascular development. Conditional knockdown of Etv2 at early,
but not later stages, severely perturbed vascular morphogenesis,
demonstrating that its function is only required during an early
window of development in which the ﬁrst endothelial progenitors
are known to emerge. This early functional restriction is likely due
to the highly dynamic expression of etv2, which peaks during
somitogenesis but is barely detectable by 24 hpf in the zebraﬁsh
embryo. Our results are consistent with recent studies in mouse
embryonic stem cells where Etv2 expression can be detected in
Brachyury-positive mesodermal cells that have not yet initiated
expression of endothelial markers, such as kdr/vegfr-2 (Wareing
et al., 2012). Furthermore, etv2 expression also appears to be
reduced in mouse embryos as development proceeds (Ferdous
et al., 2009). Finally, conditional ablation of etv2 in mouse embryos
using a Kdr:Cre driver does not effect endothelial differentiation or
vascular morphogenesis (Wareing et al., 2012), suggesting that
etv2 is also dispensable for later steps in vascular development in
mammals as well. Taken together with our studies, these results
suggest that Etv2 plays an essential and conserved role to commit
early lateral mesoderm progenitors to an endothelial cell lineage.
Despite these observations, we still do not understand the precise
molecular mechanisms by which Etv2 acts in this regard. While
Etv2 is capable of directly activating functional downstream
targets, such as Kdr {Ishitobi, 2011 #47;Lee, 2008 #36}, a more
comprehensive identiﬁcation of Etv2 target genes, and a better
understanding of how Etv2 induces their expression, is essential to
understand the role of this transcription factor in endothelial
commitment.
In many cases, ETS transcription factors are essential through-
out the ontogeny of a particular cell lineage, often acting reitera-
tively during commitment and differentiation. For example, Spi1
(also known as pu.1) is essential for development of the myeloid
lineage (McKercher et al., 1996; Scott et al., 1994), where it is
required for early expression of receptors for macrophage and
granulocyte speciﬁc growth factors on progenitor cells (Anderson
et al., 1998a). Subsequently, spi1 plays an essential role in the
terminal differentiation and function of both macrophages and
neutrophils, where it continues to be expressed (Anderson et al.,
1998a, 1998b). By contrast, Etv2 function is restricted to early
endothelial commitment and its persistent expression has dele-
terious effects on differentiation and vascular morphogenesis.
Continued endothelial expression of a Cre-activated conditional
ROSA26:Etv2 transgene in mouse embryos leads to abnormal yolk
sack vascular morphology and a failure to induce expression of
genes involved in vascular maturation (Hayashi et al., 2012). A
similar effect is observed during direct endothelial reprogramming
of human amniotic cells, which requires ETV2, along with ERG and
FLI1 (Ginsberg et al., 2012). While ETV2 is essential for direct
reprogramming in this context, it must be subsequently down-
regulated for normal endothelial differentiation to occur (Ginsberg
et al., 2012). Together with our ﬁndings, these studies underscore
the need to actively repress etv2 expression to allow normal
endothelial differentiation.
Our results suggest that miRNA-mediated post-transcriptional
repression plays an important role in reducing the levels of Etv2 to
allow normal differentiation. The etv2 3'UTR is capable of mediat-
ing repression in endothelial cells and Etv2 protein persists in
MZdicer1 mutant embryos, which lack miRNAs. We further ﬁnd
that post-transcriptional repression of etv2 is mediated, in part, by
members of the let-7 family of microRNAs. Our results are
consistent with the role of let-7 microRNAs in other animal
species, where they are known to promote cellular differentiation
or block transformation by negatively regulating genes associated
with growth and proliferation, such as RAS and MYC (Chang et al.,
2009; Johnson et al., 2005; Thornton and Gregory, 2012; Yu et al.,
2007). We also ﬁnd evidence for multiple etv2 transcript isoforms
with different length 3'UTRs, which varied in their potential to
repress reporter expression and their responsiveness to let-7 over-
expression. While only the shortest 3'UTR did not appreciably
repress reporter gene expression in our endothelial autonomous
sensor assay, it retained two let-7 binding sites and could still be
partially repressed by let-7a. Importantly, let-7 potently repressed
endogenous Etv2 protein levels, suggesting an important role for
this miRNA in regulating etv2 in vivo. However, the precise role of
alternative 3'UTR usage in etv2 regulation is not clear at this time.
Interestingly, previous studies demonstrate that shortened 3'UTRs,
which can presumably evade microRNA regulation, are prevalent
in proliferating or transformed cells (Mayr and Bartel, 2009;
Sandberg et al., 2008). Furthermore, 3'UTRs generally lengthen
during zebraﬁsh emrbyogenesis as cells differentiate (Ulitsky et al.,
2012). These observations suggest that there may be a transition in
etv2 3'UTR usage as lateral mesodermal progenitors commit to the
endothelial lineage and begin to differentiate, allowing let-7 to
contribute to Etv2 down-regulation during this process.
Despite the effect of let-7a on endogenous Etv2 expression, we
did not note any vascular defects caused by over-expressing lin28a,
which drastically reduced let-7a levels. In addition, lin28a over-
expression did not appear to cause Etv2 to persist at later stages.
There could be several reasons for these results. First, the degree of
let-7a knockdown caused by exogenous lin28a expression, while
signiﬁcant based on our quantiﬁcation, may not be sufﬁcient to
mimic a true genetic null given the number and diversity of let-7
microRNAs expressed in endothelial cells at this time point (Nicoli
et al., 2012). Thus, sufﬁcient levels of let-7 microRNAs may remain
to repress Etv2 even in the presence of high levels of Lin28a.
Future application of lin28a transgenes that would allow persis-
tent high level expression throughout development are likely
required to fully address this issue. Second, other miRNAs may
contribute to Etv2 repression in the absence of let-7 family
members. While we are currently not able to distinguish these
possibilities, the persistent expression of Etv2 protein in MZdicer1
mutant embryos underscores the importance of miRNAs in med-
iating its repression during development. Finally, there are likely
to be additional regulatory mechanisms that contribute to Etv2
down-regulation and may be sufﬁcient to allow normal vascular
development in the absence of let-7. Indeed, while Etv2 protein
persisted in MZdicer1 mutant embryos, etv2mRNAwas reduced as
development proceeded similar to wild type siblings. Although
exogenous let-7a appeared to reduce etv2 transcript following
whole embryo analysis, comparison of in situ results and
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immunostaining suggested a much more potent effect on Etv2
protein rather than mRNA levels. Furthermore, the observed
decrease in etv2 mRNA was likely due to embryos displaying
fewer angioblasts, a phenotype associated with Etv2 deﬁciency
(Pham et al., 2007; Sumanas and Lin, 2006) and consistent with
the observed reduction in Etv2 protein following let-7a over-
expression. Together, these observations suggest that down-
regulation of etv2 mRNA may also occur through transcriptional
mechanisms. Consistent with this possibility, a recent study has
identiﬁed an enhancer element in the zebraﬁsh etv2 locus that
drives expression in endothelial cells only during early stages of
embryonic development but not later (Veldman and Lin, 2012).
The activity of this enhancer mirrors that which we observe for
the endogenous transcript, suggesting that transcriptional
mechanisms can contribute to the dynamic expression of etv2.
Thus, while our work suggests that miRNA-mediated post-tran-
scriptional repression contributes to Etv2 down-regulation, it is
likely that other mechanisms also play an important role in this
process.
Whether let-7 or other miRNAs contribute to the repression of
Etv2 in mammals is unknown. We did observe that human and
mouse ETV2 3' UTRs also contain let-7 binding sites (data not
shown). Moreover, zebraﬁsh and human endothelial cells highly
express several let-7 family members (Kuehbacher et al., 2007),
but do not express appreciable amounts of ETV2 (Djebali et al.,
2012). These observations suggest that let-7-mediated repression
of etv2 may be a conserved aspect of its regulation. Based on its
powerful ability to induce endothelial gene programs and block
differentiation, along with the evidence that it is normally actively
repressed, we would further speculate that Etv2 is likely to play a
role in the pathogenesis of syndromes associated with dysregu-
lated endothelial growth. In this regard, it will be of interest to
determine if etv2 expression is persistent in cases of infantile
hemangioma or angiosarcoma. At the same time, further investi-
gation into the mechanisms that contribute to etv2 regulation will
likely provide novel insights into how this master regulator
contributes to endothelial lineage speciﬁcation.
Material and methods
Zebraﬁsh handling and maintenance
Zebraﬁsh and their embryos were handled according to standard
protocols (Westerﬁeld, 1993) and in accordance with the University of
Massachusetts Medical School IACUC guidelines. Tg(ﬂi1a:egfp)y1, Tg
(ﬂi1a:negfp)y7 and Tg(ﬂi1a.ep:DsRedex)um13 lines have been described
(Covassin et al., 2009; Lawson and Weinstein, 2002; Roman et al.,
2002). Maternal zygotic (MZ) dicer1 embryos were made using the
germline replacement technique as previously described (Ciruna et al.,
2002; Giraldez et al., 2005) using dicer1hu715 donors (Wienholds et al.,
2003).
Etv2 caged Morpholino injections
The Etv2 caged morpholino (cMO) used in this study has been
previously reported (Ouyang et al., 2009). 230 fmol (2 ng) of Etv2
cMO was injected into Tg(ﬂi1a.ep:DsRedEx)um13 embryos at 1-cell
stage. Embryos were subjected to UV illumination for 10 s at
indicated stages using a Zeiss Axioskop2 Plus compound micro-
scope with a DAPI ﬁlter and an Achroplan (Zeiss) 20 water
immersion objective. Following photoactivation, embryos were
grown in egg water at 28.5 1C. Control embryos were left in the
dark. 5 ng of scrambled control or 5 ng Etv2 MO (Sumanas and Lin,
2006) were injected as negative and positive controls, respectively.
Vascular morphology was assessed at 30 hpf. Embryos were imaged
using an MZFLIII ﬂuorescent dissection microscope or using a using
a Leica DMIRE2 confocal microscope (Objective: HC PL APO 20
/0.70CS). Circulatory defects were observed at 48 hpf using a MZ12
stereomicroscope (Leica) and captured with a DMK21F04 camera
(Imagesource) using Quicktime Pro or iMovie.
Plasmid construction
The etv2 open reading frame was ampliﬁed from 24 hpf whole
embryo cDNA and used in a BP recombination reaction with
plasmid pDONR221 (Invitrogen) to make pME-etv2. The zebraﬁsh
lin28a open reading frame was ampliﬁed from a full-length
Zebraﬁsh Gene Collection (ZGC) clone (Clone ID: 2643384; Thermo
Scientiﬁc; see Supplementary Table 1 for primers), then subjected
to BP recombination with plasmid pDONR221 to generate pME-
lin28a. pME-etv2, pME-lin28a, or pME-mcherry (Nicoli et al., 2010)
were used in LR reactions with pCSDest or pCSMTDest (Villefranc
et al., 2007) to generate pCS-etv2, pCSMT-etv2, pCS-lin28a, and
pCS-mCherry. Alternative etv2 3' UTRs were cloned through PCR
ampliﬁcation using attB2 and attB3 primers (see Supplementary
Table 1) followed by BP recombination into pDONRP2r-P3 (Invi-
trogen) to give p3E-EST etv2 3'UTR, p3E-short etv2 3'UTR and p3E-
long etv2 3'UTR. let-7 binding sites were identiﬁed by miRANDA,
RNAhybrid, and a perl script. Bases 1, 3, 4, 5, 6 were mutated to
adenines within 5 identiﬁed let-7 binding site seed sequences
(Ramachandran et al., 2010) identiﬁed by all three methods. The
mutant let-7 etv2 3' UTR fragment was synthesized by Genewiz
(pUC57-kan-etv2_3putr_mut_let7) followed by subcloning into
p3E-mcs1 with AscI and XhoI to give p3E-mutlet-7 etv2 3' UTR.
To generate mRNA sensors constructs, p3E-ESTetv2 3'UTR or p3E-
shortetv2 3'UTR were recombined with pCSDEST2 and pENTR-
EGFP2 (Villefranc et al., 2007) to yield pCS2-egfp-ESTetv2 3'UTR
and pCS2-egfp-shortetv2 3'UTR. Endothelial 3' UTR sensor con-
structs were generated by performing an LR Gateway recombina-
tion reaction between pTolBasPegfpﬂiEPmcherryR2–R3 and one of
the following 3' entry clones: p3E-mcs1, p3E-shortEtv2-3'UTR,
p3E-ESTEtv2-3'UTR, p3E-longEtv2-3'UTR, p3E-mut-let7-Etv2-3'UTR.
mRNA synthesis and injections
Capped mRNA was synthesized from pCS plasmids that had
been linearized with NotI using the SP6 mMessage mMachine kit
(Ambion). mRNAs were injected into 1-cell stage embryos accord-
ing to standard protocols (Westerﬁeld, 1993).
3'UTR sensor assays
For whole embryo sensor assay, 50 pg of mCherry mRNA and
50 pg of indicated gfp etv2 3' UTR mRNA was co-injected along
with 2 nl of a 50 μM stock of indicated miRNA duplexes into 1-cell
stage zebraﬁsh embryos. Embryos were visualized at 24 hpf using
an MZFLIII dissection microscope equipped with epiﬂuorescence
and digital images were captured using an AxioCam mRC (Zeiss).
Alternatively, equal numbers of dechorionated embryos were
lysed by boiling in 2 Laemmli buffer. Lysates were run on an
SDS–PAGE gel and transferred to Western blots, which were
probed with antibodies against EGFP (Invitrogen) and mCherry
(Clontech). Blots were stripped in between each antibody detec-
tion. Expression levels were quantiﬁed by measuring the optical
density of bands using ImageJ following incubation with a horse-
radish peroxidase conjugated secondary antibody and chemilu-
minscence detection. For endothelial autonomous sensor assays,
25 pg of indicated pTol sensor construct was co-injected with
25 pg transposase mRNA into one-cell stage wild type embryos.
Individual 3'UTR constructs were always injected with control
sensor in parallel. At 24 hpf, embryos were transferred to egg
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water containing 0.2 mM 1-phenyl-2-thiourea (PTU) to inhibit the
pigment formation. At 48–50 hpf, approximately ﬁve embryos
from each group per experiment displaying robust transgenesis
were imaged by confocal microscopy. Gain settings were set using
embryos injected with the control sensor and remained constant
throughout the experiment. Quantiﬁcation of ﬂuorescence levels
was performed using Imaris by creating a surface based on GFP
ﬂuorescence and examining the average values intensity sum of
green and red channels. The red/green ratio of an experimental
embryo was normalized against the red/green ratio of a control
embryo imaged on the same day. All sensor experiments were
done and quantiﬁed in quadruplicate using at least 5 embryos per
experiment except the EST-3'UTR which was done in triplicate.
Signiﬁcance was calculated by a Welsh test and signiﬁcance
determined by a p valueo0.03.
Antibody production
A fragment encoding the N-terminal 218 amino acids of
zebraﬁsh Etv2 was ampliﬁed from 24 hpf zebraﬁsh cDNA (see
Supplementary Table 1 for primers), cloned into pCR2.1 by TOPO
cloning (Invitrogen), and veriﬁed by sequencing. The etv2 frag-
ment was subcloned into pGEX-6P-1 using BamHI and XhoI sites.
pGEX-Etv2 was transformed into BL21(DE3) and glutathione
S-transferase (GST) fusion protein expression was induced with
IPTG. Expressing bacteria were lysed using Bug Buster (Novagen),
and proteins were puriﬁed using Glutathione Sepharose 4B(GE
Healthcare), followed by release of the Etv2 fragment and removal
of the GST using PreScission Protease (GE Healthcare). Puriﬁed
Etv2 protein was used for rabbit polyclonal antibody production
(Caprologics, Gilbertville, MA). Etv2 antiserum was validated using
Western analysis of lysates from HEK293T over-expressing myc-
tagged zebraﬁsh Etv2. The myc epitope was detected using a
1:10,000 dilution of 9E10 (Sigma) and Etv2 protein was detected
using a 1:5000 dilution of anti-Etv2 polyclonal antibody serum.
Whole mount immunostaining
Staged zebraﬁsh embryos were ﬁxed overnight at 4 1C in 2%
paraformaldehyde (w/v) dissolved in phosphate buffered saline
containing 0.1% Tween-20 (PBSTw). Embryos were washed 4 times
for 5 min at room temperature in PBSTw and in PBS containing
0.5% TritonX-100 (PBSTr) at room temperature for 30 min.
Embryos were blocked for a minimum of 2 h in blocking solution
(PBSTw, 0.1% TritonX-100, 10% normal goat serum, 1% BSA, 0.01%
sodium azide) at room temperature. Fli1b and Etv2 rabbit poly-
clonal serum was diluted 1:1000 and 1:500, respectively, in
blocking solution and embryos incubated over night at 4 1C.
Embryos were washed 6 times in PBSTw for at least 4 h at room
temperature and then incubated overnight with Alexa Fluor 488 or
Alexa Fluor 568 (Invitrogen) anti-rabbit secondary antibody
diluted 1:1000 in blocking solution. Immunostained embryos were
imaged on a LSM7 MP microscope (Zeiss; Objective: 20 /1.0 DIC
(UV) VIS-IR 421452-9800) equipped with a Chameleon Ti:Sapphire
pulsed laser (Coherent, Inc.). Alexa Fluor 488 and Alexa Flour 568
were alternatively excited at 904 nm and 1057 nm, respectively, on
each section during image acquisition.
miRNA duplexes
RNA oligonucleotides (Integrated DNA technologies) corre-
sponding to the mature and star sequences of zebraﬁsh let-7a,
let-7c, let-7f, and, let-7g (see Supplementary Table 1) were diluted
to 250 μM in nuclease-free water. Equal volumes of mature
and star oligonucleotides were combined, heated to 95 1C and
annealed at 37 1C for 30 min. miRNA duplexes were aliquotted and
stored at 80 1C. 2 nl of 50 μMmiRNA duplexes were injected into
embryos. A mis-match duplex in which 4 out of 8 bases in the seed
sequenced were changed (Supplementary Table 1) was used as a
negative control (referred to as “control duplex”).
Quantiﬁcation of endothelial gene expression
Transcript levels were quantiﬁed using the NanoString nCoun-
ter gene expression system (Nanostring Technologies, Seattle, WA;
(Geiss et al., 2008)). Total RNA was isolated from embryos using a
Qiagen RNAeasy kit. For embryos injected with let-7a or control
duplex, RNA was isolated at 15 ss. To assess over-expression of
Etv2 and let-7a, embryos were co-injected with let-7a duplex as
above along with 50 pg of mRNA encoding Etv2 or Etv2 minus its
DNA binding domain [Etv2(–DBD)] and RNA was isolated at shield
stage. For each experiment, 100 ng of total RNA was hybridized for
12 to 20 h with the Nanostring probeset (Supplementary Table 2)
at 65 1C in a thermocycler. Samples were then loaded into the
nCounter prep station and ﬂuorescence signal was quantiﬁed
using the nCounter Digital Analyzer. Gene normalization and fold
change calculations were done using Nsolver Analysis Software
(Nanostring Technologies). In all cases, biological triplicates were
performed and gene counts were normalized to eukaryotic transla-
tion elongation factor 1 alpha 1 like 1 (eef1a1l1) and actin, beta 2
(actb2). Either the average normalized gene count or the average
fold change was plotted and error bars represent the Standard
Error of the Mean (SEM).
In situ hybridization
An antisense DIG-labeled etv2 riboprobe was synthesized by
linearizing pCS2-etv2 with EcoRI followed by in vitro transcription
using T7 polymerase. A gata1a riboprobe was synthesized as
described elsewhere (Hart et al., 2009). Whole mount in situ
hybridization was performed according to standard protocols
(Hauptmann, 1999).
Mosaic analysis
Tg(ﬂi1a:egfp)y1 embryos were used as donors in all cases and
0.35% miniRuby (dextran, tetramethylrhodamine and biotin
10,000 MW; Invitrogen) was co-injected as a lineage tracer. To
assess the effect of Etv2 overexpression, we injected 100 pg of
myc-etv2 or mCherry mRNA into 1-cell stage donor embryo. For
let-7a overexpression we injected 2 nl of either 50 μm control or
let-7a duplex. At sphere stage, approximately 20 cells were
transplanted from the ventral blastoderm margin of donors into
wild type hosts, which were subsequently screened at 30 hpf for
the appearance of red and green ﬂuorescence. Embryos were
imaged using an MZFLIII ﬂuorescent dissection microscope or
using a using a Leica DMIRE2 confocal microscope (Objective: HC
PL APO 20 /0.70CS). The proportion of successfully transplanted
embryos (i.e. exhibiting miniRuby-positive cells in any trunk
tissue) with contribution to blood vessels was determined in three
separate experiments and signiﬁcance was calculated by Fisher's
Exact test. po0.05 was deemed signiﬁcant.
Northern
Northern blot analysis for microRNA expression was performed
as previously described (Kim et al., 2010). Zebraﬁsh RNA was
isolated using a miRNeasy Micro kit (Qiagen) and 5 μg of total RNA
was loaded per lane. Blots were hybridized with a DIG labeled let-
7a locked-nucleic acid probe (Exiqon), stripped using boiling
water, and hybridized with a DIG-labeled 5s rRNA DNA probe
(see Supplementary Table 1). Chemilumenscence detection was
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performed following incubation with a horseradish peroxidase-
conjugated antibody against DIG. Northern blots were performed
using RNAs from three separate experiments and quantiﬁed by
measuring the optical density of bands using ImageJ to compare
levels in uninjected versus let-7a injected embryos. Average fold
difference from three independent experiments was plotted and
error bars represent SEM. Signiﬁcance was measured using a
student t-test.
3' RACE and Etv2 3' UTR cloning
3' RACE was performed using the SMART RACE kit (Clontech).
etv2-speciﬁc primers for primary and nested PCR are listed in
Supplementary Table 1. Ampliﬁed fragments were gel puriﬁed,
cloned into pGEM-t (Promega) and veriﬁed by sequencing.
Quantitative PCR of miRNAs
RNA was puriﬁed from uninjected zebraﬁsh embryos injected
at 24 hpf or those injected with 1 ng lin28a mRNA using a
miRNeasy micro kit (Qiagen). qRT-PCR to detect mature miRNAs
was performed using the miScript System (Qiagen). Two μg of
whole RNA was used to synthesize cDNA. qPCR was performed
from 100 ng of cDNA template with commercially available pri-
mers for indicated miRNA (Qiagen) and the miScript universal
primer using the miScript SYBR green PCR Kit (Qiagen). snord61.2
expression was assessed in parallel and used to normalize micro-
RNA expression levels. PCR quantiﬁcation was performed on a
StepOnePlus Real-time PCR system (Applied Biosystems). Each
reaction was run in triplicate and performed on at least two
experimental replicates and 2-log fold change calculated by
comparing uninjected to Lin28a injected.
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